+
JSW Group to procure vaccines for 25,000 employees and their families
ECONOMY & POLICY

JSW Group to procure vaccines for 25,000 employees and their families

As an initial step in the process of inoculating employees against Covid-19, JSW Group, a few Tata Group companies, the India unit of a major multinational, and numerous other firms have plans to begin talks with vaccine manufacturers. The employees working at manufacturing units are more vulnerable than those working from home, and will receive priority treatment.

The first shots of the vaccine will be available from as early as March. According to sources, around two to three lakh doses will be supplied. Serum Institute of India began delivering its Covishield vaccines last week, followed by Bharat Biotech with the homegrown Covaxin. The initial focus is to vaccinate healthcare and frontline professionals by July.

Tata Group said that some of the companies in the conglomerate have initiated discussions on procuring vaccines, but a decision hasn't been taken yet, as informed by sources.

The India unit of a multinational manufacturing company is awaiting communication from the parent, which has initiated talks with global vaccine manufacturers for its units in North America and Europe.

Instead of depending on Serum Institute and Bharat Biotech alone, companies are waiting for more vaccines to come into the market. Four other companies are in different stages of conducting trials including Russia's Sputnik vaccine that will be distributed by Dr Reddy's Lab in India, and Zydus Cadila, which recently got the nod for third phase trials.

As companies await better clarity on the supply of vaccines, some wonder whether vaccination of employees could be included under corporate social responsibility.

Image source

As an initial step in the process of inoculating employees against Covid-19, JSW Group, a few Tata Group companies, the India unit of a major multinational, and numerous other firms have plans to begin talks with vaccine manufacturers. The employees working at manufacturing units are more vulnerable than those working from home, and will receive priority treatment. The first shots of the vaccine will be available from as early as March. According to sources, around two to three lakh doses will be supplied. Serum Institute of India began delivering its Covishield vaccines last week, followed by Bharat Biotech with the homegrown Covaxin. The initial focus is to vaccinate healthcare and frontline professionals by July. Tata Group said that some of the companies in the conglomerate have initiated discussions on procuring vaccines, but a decision hasn't been taken yet, as informed by sources. The India unit of a multinational manufacturing company is awaiting communication from the parent, which has initiated talks with global vaccine manufacturers for its units in North America and Europe. Instead of depending on Serum Institute and Bharat Biotech alone, companies are waiting for more vaccines to come into the market. Four other companies are in different stages of conducting trials including Russia's Sputnik vaccine that will be distributed by Dr Reddy's Lab in India, and Zydus Cadila, which recently got the nod for third phase trials. As companies await better clarity on the supply of vaccines, some wonder whether vaccination of employees could be included under corporate social responsibility. Image source

Related Stories

Gold Stories

Next Story
Infrastructure Energy

Perkins Begins Production of 5016 Power Generation Engine

Perkins has commenced production of its new 5016 full-authority electronic engine, completing its 5000 Series range of 6-, 8-, 12- and 16-cylinder engines. Manufactured in Stafford, UK, and Aurangabad, India, the range delivers up to 2,500 kVA of standby power and 2,250 kVA of prime power.The 61-litre V16 engine delivers 1,400–2,500 kVA at 50 Hz for base load, prime and standby applications. Designed for power generation, it supports critical infrastructure, including data centres, hospitals, airports and remote worksites.Engineered to meet ISO G3 and NFPA110 standards, the 5016 incorporates..

Next Story
Real Estate

JAPAN BUILD Tokyo 2026 Expects 35,000 Visitors

RX Japan GK will organise the 11th edition of JAPAN BUILD Tokyo at Tokyo Big Sight from 2–4 December 2026, with approximately 35,000 visitors expected from the building, construction and real estate sectors.The exhibition will bring together manufacturers, developers, contractors, architects, distributors and property owners. According to the organiser, 51.2 per cent of visitors hold managerial positions or above, providing exhibitors with opportunities to engage with procurement decision-makers. The previous edition attracted 33,618 visitors and 548 exhibitors.JAPAN BUILD Tokyo will feature..

Next Story
Infrastructure Urban

Magma Signs LOIs Worth Over Rs 8 Bn Across Industrial Businesses

Magma has signed Letters of Intent (LOIs) worth more than Rs 8 bn across its advanced materials, waste management, precision engineering and digital industrial solutions businesses.The company expects to execute around 70 per cent of the current LOI pipeline during FY27, providing visibility for the remainder of the financial year. The pipeline reflects rising demand from enterprise manufacturers and deeper engagement across Magma’s customer relationships.India’s industrial B2B trade is estimated at around USD 2 trillion. In precision engineering, imports account for 60-65 per cent of high..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code